Spectral is a Phase III company seeking U.S. FDA approval for its lead theranostics product for the treatment of septic shock. Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. Directed by the Company s Endotoxin Activity Assay EAA , the only FDA cleared diagnostic for the risk of developing sepsis, Spectral s EUPHRATES trial is the world s first theranostics trial in the area of sepsis.
Quote | Spectral Medical Inc (OTCMKTS:EDTXF)
Last: | $0.3217 |
---|---|
Change Percent: | 0.0% |
Open: | $0.3217 |
Close: | $0.3217 |
High: | $0.3217 |
Low: | $0.3217 |
Volume: | 500 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Spectral Medical Inc (OTCMKTS:EDTXF)
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that Anthony (Tony) Bihl III, Spectral’s C...
2024-03-28 17:14:24 ET More on Spectral Medical Baxter extends distribution deal with Spectral for sepsis product Historical earnings data for Spectral Medical Financial information for Spectral Medical Read the full article on Seeking Alpha For furth...
Message Board Posts | Spectral Medical Inc (OTCMKTS:EDTXF)
Subject | By | Source | When |
---|---|---|---|
If "winner" is the firm that people are | Lakersrback | investorshub | 11/20/2020 3:38:56 AM |
Ctso is the clear winner | Harbor6460 | investorshub | 11/18/2020 9:21:08 PM |
I love modest Canadian companies! | Lakersrback | investorshub | 11/03/2020 1:55:30 AM |
Mucho monkee business here. Very tightly held | Lakersrback | investorshub | 10/15/2020 6:02:16 PM |
Well I bought 20k shares at 0.50 this | eskay1954 | investorshub | 05/08/2020 10:22:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Spectral Medical Inc Company Name:
EDTXF Stock Symbol:
OTCMKTS Market:
Spectral Medical Inc Website:
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that Anthony (Tony) Bihl III, Spectral’s C...
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and ...
Bitdeer Technologies Group (BTDR) is expected to report $0.11 for Q4 2023 BioForce Nanosciences Holdings Inc (BFNH) is expected to report for Q4 2023 Casino Guichard Perrachon ADR (CGUSY) is expected to report for quarter end 2023-12-31 Motorsport Games Inc. (MSGM) is expected to repo...